Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

And a blockbuster deal could be announced at any t

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72446
(Total Views: 335)
Posted On: 04/23/2019 6:33:48 PM
Posted By: Lemoncat
Re: bandg #55370
Quote:
And a blockbuster deal could be announced at any time.



Can you provide some parameters as to what you feel a blockbuster deal entails? None of the dreamers seem to want to do so.

I would consider a $50M + $200M milestones + 12% royalty to be a blockbuster deal at this point, would you?


You have to understand how hard Leo's job is right now:

He has to convince risk-averse pharma to pay up on a very limited set of trial data. He has to conduct these negotiations with next to no money and no BTD. The only real way to get pharma to pay up is to entice two or more into a bidding war. Even then, they will only bid so high on a trial arm with 7-8 dosed PP.

I think getting pharma to pay up big ($100M+ upfront) for B-OM from our current negotiating position will be an amazing feat. I think our best case is to have a small upfront with a large milestone payment for achieving BTD at the interim look.


Quote:
"the fluff he has to work with"



He's doing his absolute best to keep our stock price as high as possible. He has not been dealt a great hand of cards as of late. No BTD, Prurisol failure, total loss of any clinically meaningful funding vehicle that does not destroy shareholders. He's doing his best with some patent announcements, pre-clinical tests and regulatory meetings. It's his duty to shareholders to reduce dilution by increasing the stock price. He has to work with what he has.

So yes, I'm a true believer. I believe he's doing anything he can to secure a deal and ensure the survival of IPIX so that we can move our pipeline forward. I pray that he succeeds.


(0)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us